Quest Diagnostics DGX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$1.72M (11 inflow days, 9 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 30.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 3.01% to 3.39% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q4 | +2,941,193 | 3.8% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q4 | +298,436 | 0.4% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q4 | +290,910 | 1.3% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q4 | +253,766 | 0.3% |
| Fidelity International Ltd | Mutual Fund | 2026/Q4 | +213,687 | 0.4% |
| Gilder Gagnon Howe & Co. LLC | Mutual Fund | 2026/Q4 | +208,595 | 0.2% |
| Jane Street Group, LLC | Private Company | 2026/Q4 | +200,668 | 0.2% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q4 | +177,299 | 0.9% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q4 | +173,534 | 0.3% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q4 | +131,084 | 0.1% |
| Samlyn Capital, LLC | Hedge Fund | 2026/Q4 | +117,407 | 0.1% |
| Millennium Management LLC | Hedge Fund | 2026/Q4 | +107,544 | 0.1% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q4 | +98,179 | 0.4% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q4 | +97,901 | 0.3% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q4 | +90,809 | 0.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 8 Nov 2026 | Patrick Plewman | Senior Vice President of Diagnostic Services | Automatic Disposition | -650 | $257.34 | 14,684 |
| 8 Nov 2026 | Patrick Plewman | Senior Vice President of Diagnostic Services | Derivative Exercise and Sale | -11,067 | $257.34 | 14,684 |
| 2 Nov 2026 | Catherine Doherty | Executive Vice President of Regional Businesses | Other Acquisition | +4,827 | – | 76,501 |
| 2 Nov 2026 | Catherine Doherty | Executive Vice President of Regional Businesses | Derivative Exercise and Sale | -22,105 | $251.24 | 76,501 |
| 2 Nov 2026 | Mark Delaney | Chief Commercial Officer | Other Acquisition | +2,615 | – | 12,975 |
| 2 Nov 2026 | Ramachandran Subu | Other Acquisition | +352 | – | 352 | |
| 2 Nov 2026 | Ramachandran Subu | Other Derivative Acquisition | +1,386 | $248.61 | 1,386 | |
| 31 Oct 2026 | Ramachandran Subu | Initial Statement of Beneficial | +0 | – | 12,052 | |
| 25 Oct 2026 | Gary Pfeiffer | Independent Director | Automatic Disposition | -1,203 | $243.00 | 916 |
| 25 Oct 2026 | Gary Pfeiffer | Independent Director | Intent to Sell (Form 144) | -1,203 | $243.00 | – |
| 20 Oct 2026 | Patrick Plewman | Senior Vice President of Diagnostic Services | Other Acquisition | +41 | $235.94 | 15,334 |
| 20 Oct 2026 | Timothy Main | Independent Director | Other Acquisition | +18 | $235.94 | 27,478 |
| 20 Oct 2026 | Robert Carter | Independent Director | Other Acquisition | +10 | $235.93 | 2,372 |
| 20 Oct 2026 | Vicky Gregg | Independent Director | Other Acquisition | +63 | $235.94 | 18,449 |
| 20 Oct 2026 | Wright Lassiter | Independent Director | Other Acquisition | +6 | $235.96 | 8,827 |
| 20 Oct 2026 | Sam Samad | Chief Financial Officer | Other Acquisition | +90 | $235.94 | 33,568 |
| 20 Oct 2026 | Mark Delaney | Chief Commercial Officer | Other Acquisition | +25 | $235.94 | 10,360 |
| 20 Oct 2026 | Karthik Kuppusamy | Senior Vice President of Clinical Solutions | Other Acquisition | +33 | $235.94 | 15,674 |
| 30 Sep 2026 | Timothy Wentworth | Director | Other Derivative Acquisition | +135 | – | 477 |
| 31 Aug 2026 | James Davis | Chairperson & CEO | Automatic Disposition | -10,000 | $242.72 | 122,423 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 3,734,103 | 3.4% | 3.6 |
| 15 Oct 2026 | 3,573,902 | 3.2% | 3.4 |
| 30 Sep 2026 | 3,417,577 | 3.1% | 2.7 |
| 15 Sep 2026 | 3,600,559 | 3.3% | 3.7 |
| 31 Aug 2026 | 3,445,561 | 3.1% | 3.9 |
| 14 Aug 2026 | 3,321,414 | 3.0% | 4.7 |
No comments yet — be the first to weigh in on DGX.
Sign in to join the discussion.